Investigational Drug Details
| Drug ID: | D397 |
| Drug Name: | ZSP1601 |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | PDE inhibitor |
| Therapeutic Category: | Hepatoprotectants |
| Clinical Trial Progress: | Phase 1&2 completed (NCT04140123) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0237 | NCT04140123 | Phase 1/Phase 2 | Completed | No Results Available | June 23, 2020 | October 11, 2021 | Details |
| L0308 | NCT03392779 | Phase 1 | Completed | No Results Available | January 5, 2018 | August 13, 2019 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title | |
|---|---|---|---|---|
| A47688 | 33682556 | Expert Opin Investig Drugs | Safety, tolerability, and pharmacokinetics of the novel pan-phosphodiesterase inhibitor ZSP1601 in healthy subjects: a double-blinded, placebo-controlled first-in-human single-dose and multiple-dose escalation and food effect study. | Details |